Future Fund LLC Acquires Shares of 44,291 Privia Health Group, Inc. $PRVA

Future Fund LLC acquired a new stake in shares of Privia Health Group, Inc. (NASDAQ:PRVA) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 44,291 shares of the company’s stock, valued at approximately $1,050,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in PRVA. Hantz Financial Services Inc. lifted its holdings in shares of Privia Health Group by 456.2% during the fourth quarter. Hantz Financial Services Inc. now owns 1,129 shares of the company’s stock valued at $27,000 after acquiring an additional 926 shares during the period. Global Retirement Partners LLC lifted its holdings in shares of Privia Health Group by 579.8% during the fourth quarter. Global Retirement Partners LLC now owns 1,584 shares of the company’s stock valued at $38,000 after acquiring an additional 1,351 shares during the period. Canada Pension Plan Investment Board lifted its holdings in shares of Privia Health Group by 48.0% during the second quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company’s stock valued at $85,000 after acquiring an additional 1,200 shares during the period. GAMMA Investing LLC raised its holdings in shares of Privia Health Group by 198.5% in the fourth quarter. GAMMA Investing LLC now owns 4,314 shares of the company’s stock valued at $102,000 after buying an additional 2,869 shares during the last quarter. Finally, Raymond James Financial Inc. bought a new position in shares of Privia Health Group in the second quarter valued at about $113,000. 94.48% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of research analysts recently issued reports on PRVA shares. Canaccord Genuity Group cut their price target on Privia Health Group from $35.00 to $34.00 and set a “buy” rating for the company in a report on Friday, May 8th. Evercore set a $26.00 price target on Privia Health Group in a report on Wednesday, April 8th. Truist Financial lifted their price target on Privia Health Group from $31.00 to $33.00 and gave the company a “buy” rating in a report on Monday, March 2nd. Piper Sandler reaffirmed an “overweight” rating and issued a $36.00 price target on shares of Privia Health Group in a report on Thursday, February 26th. Finally, Citigroup cut their price target on Privia Health Group from $34.00 to $32.00 and set a “buy” rating for the company in a report on Tuesday, March 3rd. Eleven research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, Privia Health Group currently has an average rating of “Moderate Buy” and a consensus price target of $31.15.

Insider Transactions at Privia Health Group

In other news, CEO Parth Mehrotra sold 105,439 shares of the business’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $22.55, for a total transaction of $2,377,649.45. Following the completion of the transaction, the chief executive officer directly owned 450,004 shares in the company, valued at approximately $10,147,590.20. The trade was a 18.98% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO David Mountcastle sold 7,179 shares of the business’s stock in a transaction dated Friday, May 1st. The stock was sold at an average price of $25.03, for a total value of $179,690.37. Following the transaction, the chief financial officer owned 214,847 shares of the company’s stock, valued at $5,377,620.41. The trade was a 3.23% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 361,330 shares of company stock worth $8,172,284. 5.70% of the stock is currently owned by company insiders.

Privia Health Group Stock Down 0.4%

Shares of PRVA stock opened at $21.51 on Friday. The stock has a 50-day moving average price of $22.65 and a 200 day moving average price of $23.07. The firm has a market cap of $2.71 billion, a price-to-earnings ratio of 134.45, a PEG ratio of 1.73 and a beta of 0.96. Privia Health Group, Inc. has a 12 month low of $18.77 and a 12 month high of $26.51.

Privia Health Group (NASDAQ:PRVA) last announced its quarterly earnings data on Thursday, May 7th. The company reported $0.19 EPS for the quarter, topping analysts’ consensus estimates of $0.08 by $0.11. The firm had revenue of $603.85 million during the quarter, compared to analyst estimates of $560.99 million. Privia Health Group had a return on equity of 2.81% and a net margin of 0.97%.The company’s revenue was up 25.8% on a year-over-year basis. During the same period last year, the company earned $0.22 earnings per share. Sell-side analysts predict that Privia Health Group, Inc. will post 0.32 earnings per share for the current fiscal year.

About Privia Health Group

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.